Zobrazeno 21 - 30
of 43
pro vyhledávání: ''
Autor:
Jianping Zhang, Chao Liang, Liangzhu Feng, Qin Zhang, Ming Qi, Ziliang Dong, Rong Chai, Changchun Wang, Yipengchen Yin, Weiwei Fei, Yongjing Li, Jiaxin Sun, Sheng Wang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-13 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background The recently developed biomimetic strategy is one of the mostly effective strategies for improving the theranostic efficacy of diverse nanomedicines, because nanoparticles coated with cell membranes can disguise as “self”, evade the su
Autor:
Xing Chen, Renjun Pei, Qishi Du, Li Liu, Dongping Huang, Dong Chen, Qunjiao Jiang, Xiaobo Yang, Gang Huang, Qiuying Li, Yi Cao
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-15 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Owing to high genetic diversities of tumor cells and low response rate of standard chemotherapy, patients with triple negative breast cancer (TNBC) have short progression-free survivals and poor outcomes, which need to explore an effective
Autor:
Xiangming Mao, Xuefeng Zhang, Fangpeng Shu, Kaihui Wu, Xumin Zhou, Guochang Liu, Jianming Lu, Junqi Luo, Wenbin Chen, Taowei Yang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-13 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
The integration of multiple functions with organic polymers-based nanoagent holds great potential to potentiate its therapeutic efficacy, but still remains challenges. In the present study, we design and prepare an organic nanoagent with oxygen-evolv
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-13 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
BackgroundPhototherapy is a promising strategy for cancer therapy by reactive oxygen species (ROS) of photodynamic therapy (PDT) and hyperthermia of photothermal therapy (PTT). However, the therapeutic efficacy was restricted by tumor hypoxia and the
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-11 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background There is a strong need for non-invasive and patient-friendly delivery systems of protein drugs for long-term therapy. However, oral delivery of protein drugs is a big challenge due to many barriers including instability in the gastrointest
Autor:
Chunmei Hu, Dongfang Liu, Yinan Ding, Chen He, Kangli Xue, Qiusha Tang, Xihui Wang, Yanli An, Zhiyuan Zhang, Rui Yang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-17 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Glioblastoma (GBM) is the most invasive primary intracranial tumor, and its effective treatment is one of the most daunting challenges in oncology. The blood–brain barrier (BBB) is the main obstacle that prevents the delivery of potentia
Autor:
Zihua Zhou, Yake Liu, Jin-Hua Gu, Fan Liu, Dalong Ni, Weinan Zhang, Wenfeng Zhu, Huanjian Sun
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-14 (2020)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
As a main element in the hard metal industry, cobalt is one of the major components of human metal implants. Cobalt-containing implants, especially joint prostheses used for artificial joint replacement, can be corroded due to the complex physiologic
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-23 (2020)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Radiotherapy is an essential step during the treatment of glioblastoma multiforme (GBM), one of the most lethal malignancies. The survival in patients with GBM was improved by the current standard of care for GBM established in 2005 but has stagnated
Autor:
Seokmann Hong, Hyo Kyung Han, So Youn Ro, Hyun Woo Ma, Jae Hee Cheon, I Seul Park, Jung Min Kim, Da Hye Kim, Hyo Jeong Park, Soo Jeong Lim, Seung Won Kim, Mi Jeong Son
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-13 (2020)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Infliximab (IFX), a TNF-α blocking chimeric monoclonal antibody, induces clinical response and mucosal healing in patients with inflammatory bowel disease (IBD). However, systemic administration of this agent causes unwanted side effects. Oral deliv
Autor:
Kaikai Wang, Linfeng Xu, Hongqian Guo, Wei Chen, Xiaozhi Zhao, Wenming Cao, Guanchen Zhu, Haixiang Qin
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-13 (2020)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Chemotherapy is a standard cancer treatment which uses anti-cancer drugs to destroy or slow the growth of cancer cells. However, chemotherapy has limited therapeutic effects in bladder cancer. One of the reasons of this resistance to chemo